A community and school approach to drug prevention and early intervention with high risk elementary school children.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 24254573)

Published in J Prim Prev on June 01, 1995

Authors

J Reynolds1, D L Cooper

Author Affiliations

1: Texas Woman's University, Denton, Texas.

Articles by these authors

(truncated to the top 100)

Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol (1996) 2.44

The evolution of alpha-fetoprotein and albumin. I. A comparison of the primary amino acid sequences of mammalian alpha-fetoprotein and albumin. J Biol Chem (1981) 1.77

A national syndromic surveillance system for England and Wales using calls to a telephone helpline. Euro Surveill (2006) 1.66

Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells. J Exp Med (1991) 1.55

Bazex syndrome (acrokeratosis paraneoplastica). An analytic review. Medicine (Baltimore) (1991) 1.49

Impact of non-CTCL dermatologic diagnoses and adjuvant therapies on cutaneous T-cell lymphoma patients treated with total skin electron beam radiation therapy. Int J Radiat Oncol Biol Phys (1994) 1.44

High-dose BEAM chemotherapy with autologous peripheral blood progenitor-cell transplantation for unselected patients with primary refractory or relapsed Hodgkin's disease. Ann Oncol (2000) 1.43

Alternative splicing of CD44 pre-mRNA in human colorectal tumors. Biochem Biophys Res Commun (1994) 1.18

Clinical pharmacology and safety evaluation of Timentin. Am J Med (1985) 1.12

Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. J Clin Oncol (2004) 1.10

Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation. J Clin Oncol (1996) 1.07

Ligand binding specificity of alternatively spliced CD44 isoforms. Recognition and binding of hyaluronan by CD44R1. J Biol Chem (1994) 1.05

Degradation rates of acetylcholine receptors can be modified in the postjunctional plasma membrane of the vertebrate neuromuscular junction. J Cell Biol (1986) 1.03

The Copper T 220C: a new long-acting copper intrauterine contraceptive device. Am J Obstet Gynecol (1976) 0.99

Dosing and effectiveness of recombinant activated factor VII (rFVIIA) in congenital haemophilia with inhibitors by bleed type and location: the experience of the Haemophilia and Thrombosis Research Society (HTRS) Registry (2004-2008). Haemophilia (2012) 0.95

Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients. Clin Exp Immunol (2012) 0.95

Adhesive interactions between alternatively spliced CD44 isoforms. J Biol Chem (1995) 0.94

Temocillin concentrations in human tissues. Drugs (1985) 0.93

The variant mRNA isoform of human metastasis gene (CD44V) detected in the cell lines of human hepatocellular carcinoma. Biochem Mol Biol Int (1994) 0.93

CD44V6 expression in human colorectal carcinoma. Hum Pathol (1998) 0.92

Patient/caregiver-reported recombinant factor VIIa (rFVIIa) dosing: home treatment of acute bleeds in the Dosing Observational Study in Hemophilia (DOSE). Haemophilia (2011) 0.91

RNA synthesis in myeloma cells synchronized by isoleucine starvation. Nucleic Acids Res (1978) 0.91

Use of rituximab and irradiated donor-derived lymphocytes to control Epstein-Barr virus-associated lymphoproliferation in patients undergoing related haplo-identical stem cell transplantation. Bone Marrow Transplant (1999) 0.89

Use of recombinant activated factor VII in patients with Glanzmann's thrombasthenia: a review of the literature. Haemophilia (2014) 0.86

Thyroid lymphoma. The case for combined modality therapy. Cancer (1994) 0.86

Dermatomyositis and lichen myxedematosus. A clinical, histopathological and electron microscopic study. Dermatologica (1973) 0.85

Gonorrhea screening program in a women's hospital outpatient department: results and analysis of risk factors. J Am Vener Dis Assoc (1976) 0.85

Single-dose pharmacokinetics of intravenous clavulanic acid with amoxicillin in pediatric patients. Antimicrob Agents Chemother (1983) 0.84

Haemophilia Experiences, Results and Opportunities (HERO) Study: survey methodology and population demographics. Haemophilia (2013) 0.84

Surgical experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX. Haemophilia (2011) 0.84

Comparative analysis of three nucleic acid-based detection systems for hepatitis C virus RNA in plasma from liver transplant recipients. Mol Cell Probes (1996) 0.84

Haemophilia Experiences, Results and Opportunities (HERO) Study: influence of haemophilia on interpersonal relationships as reported by adults with haemophilia and parents of children with haemophilia. Haemophilia (2014) 0.84

A phase II study of outpatient chemotherapy with cisplatin, 5-fluorouracil, and leucovorin in nasopharyngeal carcinoma. Cancer (1994) 0.84

A phase I study of paclitaxel for mobilization of peripheral blood progenitor cells. Bone Marrow Transplant (1999) 0.82

Toxic erythema of chemotherapy following i.v. BU plus fludarabine for allogeneic PBSC transplant. Bone Marrow Transplant (2012) 0.82

Screening recombinant DNA libraries: a rapid and efficient method for isolating cDNA clones utilizing the PCR. Biotechniques (1991) 0.81

The multispecific cell adhesion molecule CD44 is represented in reticulocyte cDNA. Biochem Biophys Res Commun (1991) 0.81

Pharmacokinetics of ticarcillin and clavulanic acid (timentin) in relation to renal function. Antimicrob Agents Chemother (1986) 0.81

Exposure and safety of higher doses of recombinant factor VIIa ≥250 μg kg(-1) in individuals with congenital haemophilia complicated by alloantibody inhibitors: the Haemophilia and Thrombosis Research Society Registry experience (2004-2008). Haemophilia (2011) 0.80

Can scoring influence athletic performance? Sex and the athlete. J Am Coll Health Assoc (1975) 0.80

Neutropenic infections in 100 patients with non-Hodgkin's lymphoma or Hodgkin's disease treated with high-dose BEAM chemotherapy and peripheral blood progenitor cell transplant: out-patient treatment is a viable option. Bone Marrow Transplant (1999) 0.80

Assessing the impact of age, race, ethnicity and inhibitor status on functional limitations of patients with severe and moderately severe haemophilia A. Haemophilia (2011) 0.80

Patient- and caregiver-reported bleeding symptoms and reasons for starting and stopping treatment with recombinant factor VIIa: analysis of the Dosing Observational Study in Haemophilia (DOSE). Haemophilia (2012) 0.80

U.S. survey of surgical capabilities and experience with surgical procedures in patients with congenital haemophilia with inhibitors. Haemophilia (2011) 0.80

Hyperleukocytosis and retinal hemorrhages after chemotherapy and Filgrastim administration for peripheral blood progenitor cell mobilization. Bone Marrow Transplant (1998) 0.79

Recognizing otolaryngologic symptoms in patients with temporomandibular disorders. Cranio (1993) 0.79

Haemophilia Experiences, Results and Opportunities (HERO) study: treatment-related characteristics of the population. Haemophilia (2014) 0.79

Electromyography of masticatory muscles in craniomandibular disorders. Laryngoscope (1991) 0.79

Assessment of individual dose utilization vs. physician prescribing recommendations for recombinant activated factor VII (rFVIIa) in paediatric and adult patients with congenital haemophilia and alloantibody inhibitors (CHwI): the Dosing Observational Study in Hemophilia (DOSE). Haemophilia (2013) 0.79

Assessment of cardiac and pulmonary function in adult patients with Hodgkin's disease treated with ABVD or MOPP/ABVD plus adjuvant low-dose mediastinal irradiation. Cancer Invest (1999) 0.79

Alternatively spliced CD44 isoforms containing exon v10 promote cellular adhesion through the recognition of chondroitin sulfate-modified CD44. Exp Cell Res (1999) 0.79

DNA fingerprinting of crude bacterial lysates using degenerate RAPD primers. PCR Methods Appl (1995) 0.79

Prognostic significance of CD44 expression in adenocarcinoma of the lung. Clin Mol Pathol (1995) 0.79

Recombinant activated factor VII safety and efficacy in the treatment of cranial haemorrhage in patients with congenital haemophilia with inhibitors: an analysis of the Hemophilia and Thrombosis Research Society Registry (2004-2008). Haemophilia (2010) 0.78

Randomized comparative study of the copper T 300, Dalkon shield, and Shell Loop in parous women. Obstet Gynecol (1975) 0.78

Health-related quality of life in haemophilia patients with inhibitors and their caregivers. Haemophilia (2012) 0.78

P-glycoprotein expression and multidrug resistance in cutaneous T-cell lymphoma. Cancer Invest (2000) 0.78

Polyadenylation of RNA in a cell-free system from mouse myeloma cells. J Biol Chem (1978) 0.78

A simplified approach to stem cell mobilization in multiple myeloma patients not previously treated with alkylating agents. Bone Marrow Transplant (2003) 0.78

Chlorambucil-induced seizures. Cancer (1997) 0.78

Myofacial pain dysfunction: analysis of 476 patients. Laryngoscope (1986) 0.78

Second solid malignancies after combined modality therapy for Hodgkin's disease. J Clin Oncol (1995) 0.78

Enzymatic and molecular diagnosis of Gaucher disease. Clin Lab Med (1995) 0.78

Burkitt's lymphoma-leukemia in patients treated for Hodgkin's disease. Cancer Invest (1996) 0.78

Retention of CD44 introns in bladder cancer: understanding the alternative splicing of pre-mRNA opens new insights into the pathogenesis of human cancers. J Pathol (1995) 0.78

Interleukin-5 mRNA in three T-cell lymphomas with eosinophilia. Am J Hematol (1993) 0.77

Differential expressions of CD44 variants in tumors affecting the central nervous system. Mol Diagn (1999) 0.77

Molecular mechanisms regulating the hyaluronan binding activity of the adhesion protein CD44. J Neurooncol (1995) 0.77

Comparison of three different models of the copper T intrauterine contraceptive device. Am J Obstet Gynecol (1979) 0.77

Gallium scans in the management of patients with Hodgkin's disease: a study of 101 patients. J Clin Oncol (1997) 0.76

Editorial: Epileptics and contact sports. JAMA (1974) 0.76

Diffuse recurrent herpes simplex virus skin lesions after adequate therapy with vidarabine. Pediatr Infect Dis (1986) 0.76

Understanding the experience of caring for children with haemophilia: cross-sectional study of caregivers in the United States. Haemophilia (2014) 0.76

Application of the Cotswolds Criteria for the assessment of disease response in patients treated for Hodgkin's disease. J Clin Oncol (1995) 0.75

Re: Discordant pair analysis of rFVIIa and pd-aPCC response. Haemophilia (2011) 0.75

Late solid tumors after treatment for Hodgkin's disease. J Clin Oncol (1998) 0.75

Radiation for early-stage Hodgkin's disease? J Clin Oncol (2000) 0.75

Multidisciplinary approach to the differential diagnosis of facial, head and neck pain. J Prosthet Dent (1991) 0.75

Ergogenic aids and drugs in athletics. J Am Coll Health Assoc (1972) 0.75

Cardiac rhabdomyosarcoma. Conn Med (1988) 0.75

Familial benign chronic pemphigus of perianal skin. Arch Dermatol (1971) 0.75

President's address. J Am Coll Health Assoc (1968) 0.75

Nutrition in the athlete. Pa Med (1970) 0.75

High school football injuries. South Med J (1976) 0.75

What is fitness? Physical fitness, tranquility, and love of fellow man are essentials of happiness. R I Med J (1969) 0.75

Inhibition of poly(adenosine diphosphate-ribose) polymerase by thymidine and thymidine analogues in L1210 cells and its relationship to the potentiation of the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea but not of 3'-[3-(2-chloroethyl)-3-nitrosoureido]-3'-deoxythymidine. Cancer Res (1991) 0.75

A new diagnostic test for Gaucher disease suitable for population screening. PCR Methods Appl (1994) 0.75

Editorial: Whither go the Olympics? JAMA (1976) 0.75

Life table analysis of the effectiveness of contraceptive methods using an APL computer program. Int J Biomed Comput (1978) 0.75

Nabumetone pharmacokinetics in patients with varying degrees of renal impairment. Am J Med (1987) 0.75

Drugs and the athlete. JAMA (1972) 0.75

The response of parathyroid hormone to specific changes in either ionized calcium, ionized magnesium, or protein-bound calcium in humans. Metabolism (1991) 0.75

Restriction-fragment-length polymorphisms of 5'-flanking region of insulin I gene in BB and other rat strains. Absence of association with IDDM. Diabetes (1987) 0.75

Female athletics. JAMA (1974) 0.75

Atrophie blanche in a patient with gamma-heavy-chain disease. Arch Dermatol (1991) 0.75

Wrestling and weight fluctuations. J Am Coll Health Assoc (1973) 0.75

Preventing Chest and Upper Abdominal Pain Associated With Exercise. Phys Sportsmed (1977) 0.75

A population-based trial of beta-carotene chemoprevention of head and neck cancer. Adv Exp Med Biol (1992) 0.75

Modified insertion techniques for copper 7, copper T and progestasert intrauterine contraceptive devices. Contraception (1977) 0.75

Clinical study of a progesterone-releasing intrauterine contraceptive device. Am J Obstet Gynecol (1975) 0.75